Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 2/20 | 0.71 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.71 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.71 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.71 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.71 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.71 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.71 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.71 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.71 |
| ▸ | TMEM97 | Q5BJF2 | 2/20 | 0.71 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.71 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.71 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.71 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.71 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.71 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.71 |
| ▸ | PRNP | P04156 | 1/20 | 0.71 |
| ▸ | APP | P05067 | 1/20 | 0.71 |
| ▸ | NQO2 | P16083 | 1/20 | 0.71 |
| ▸ | MTOR | P42345 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bidesethyl Chloroquine SCHEMBL17706108 | 1.00 | CHRM2 (0.71) | CHRM2CHRM4CHRM5ADRA2ACHRM1 | |
| Bidesethyl Chloroquine SCHEMBL29625380 | 1.00 | CHRM2 (0.71) | CHRM2CHRM4CHRM5ADRA2ACHRM1 | |
| SCHEMBL24686036 | 0.90 | CHRM2 (0.74) | CHRM2CHRM4CHRM5ADRA2ACHRM1 | |
| SCHEMBL12967486 | 0.89 | CHRM2 (0.77) | CHRM2CHRM4CHRM5ADRA2ACHRM1 | |
| SCHEMBL17704778 | 0.89 | CHRM2 (0.77) | CHRM2CHRM4CHRM5ADRA2ACHRM1 | |
| SCHEMBL16702858 | 0.88 | CHRM2 (0.75) | CHRM2CHRM4CHRM5ADRA2ACHRM1 | |
| SCHEMBL24686033 | 0.88 | CHRM2 (0.74) | CHRM2CHRM4CHRM5ADRA2ACHRM1 | |
| SCHEMBL7835332 | 0.87 | NR4A2 (0.70) | CHRM2CHRM4CHRM5ADRA2ACHRM1 | |
| SCHEMBL14875102 | 0.86 | CHRM2 (0.70) | CHRM2CHRM4CHRM5ADRA2ACHRM1 | |
| SCHEMBL28585656 | 0.86 | NR4A2 (0.66) | CHRM2CHRM4CHRM5ADRA2ACHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0946744-B1 | NOVEL POLYMERIC COMPLEXES FOR THE TRANSFECTION OF NUCLEIC ACIDS, WITH RESIDUES CAUSING THE DESTABILISATION OF CELL MEMBRANES | IDM IMMUNO DESIGNED MOLECULES (FR) | 2004-08-18 | — | — | EP | claimed |
| EP-1135481-B1 | NEW OLIGOMERIC CONJUGATES LIABLE TO TRANSFER BIOLOGICAL MOLECULES INTO CELLS | IDM IMMUNO DESIGNED MOLECULES (FR) | 2004-02-25 | — | — | EP | claimed |
| US-6372499-B1 | TRANSFECTION EFFICIENCY | I.D.M. IMMUNO-DESIGNED MOLECULES (FR) | 2002-04-16 | — | — | US | claimed |
| EP-0946744-A1 | NOVEL POLYMERIC COMPLEXES FOR THE TRANSFECTION OF NUCLEIC ACIDS, WITH RESIDUES CAUSING THE DESTABILISATION OF CELL MEMBRANES | I.D.M. IMMUNO-DESIGNED MOLECULES (FR) | 1999-10-06 | — | — | EP | claimed |
| WO-1998022610-A1 | NOVEL POLYMERIC COMPLEXES FOR THE TRANSFECTION OF NUCLEIC ACIDS, WITH RESIDUES CAUSING THE DESTABILISATION OF CELL MEMBRANES | I.D.M. IMMUNO-DESIGNED MOLECULES (FR) | 1998-05-28 | — | — | WO | claimed |
| WO-2022008597-A1 | METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFECTIOUS DISEASES | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2022-01-13 | — | — | WO | disclosed |
| EP-3892275-A1 | AEROSOLIZATION OF HCQ OR ITS METABOLITES FOR THE TREATMENT OF LUNG INFECTIONS | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2021-10-13 | — | — | EP | disclosed |
| WO-2014147531-A2 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER | KANDULA MAHESH (IN) | 2014-09-25 | — | — | WO | disclosed |
| WO-2014141057-A2 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER | KANDULA MAHESH (IN) | 2014-09-18 | — | — | WO | disclosed |
| US-7410975-B2 | Small molecule toll-like receptor (TLR) antagonists | COLEY PHARMACEUTICAL GROUP, INC. (US) | 2008-08-12 | — | — | US | disclosed |
| US-7410975-B2 | Small molecule toll-like receptor (TLR) antagonists | COLEY PHARMACEUTICAL GROUP, INC. (US) | 2008-08-12 | — | — | US | disclosed |
| US-20070232622-A1 | Small molecule toll-like receptor (TLR) antagonists | COLEY PHARMACEUTICAL GMBH (DE) | 2007-10-04 | — | — | US | disclosed |
| US-20070232622-A1 | Small molecule toll-like receptor (TLR) antagonists | COLEY PHARMACEUTICAL GMBH (DE) | 2007-10-04 | — | — | US | disclosed |
| EP-0946744-B1 | NOVEL POLYMERIC COMPLEXES FOR THE TRANSFECTION OF NUCLEIC ACIDS, WITH RESIDUES CAUSING THE DESTABILISATION OF CELL MEMBRANES | IDM IMMUNO DESIGNED MOLECULES (FR) | 2004-08-18 | — | — | EP | disclosed |
| EP-1135481-B1 | NEW OLIGOMERIC CONJUGATES LIABLE TO TRANSFER BIOLOGICAL MOLECULES INTO CELLS | IDM IMMUNO DESIGNED MOLECULES (FR) | 2004-02-25 | — | — | EP | disclosed |
| US-6372499-B1 | TRANSFECTION EFFICIENCY | I.D.M. IMMUNO-DESIGNED MOLECULES (FR) | 2002-04-16 | — | — | US | disclosed |
| EP-0946744-A1 | NOVEL POLYMERIC COMPLEXES FOR THE TRANSFECTION OF NUCLEIC ACIDS, WITH RESIDUES CAUSING THE DESTABILISATION OF CELL MEMBRANES | I.D.M. IMMUNO-DESIGNED MOLECULES (FR) | 1999-10-06 | — | — | EP | disclosed |
| WO-1998022610-A1 | NOVEL POLYMERIC COMPLEXES FOR THE TRANSFECTION OF NUCLEIC ACIDS, WITH RESIDUES CAUSING THE DESTABILISATION OF CELL MEMBRANES | I.D.M. IMMUNO-DESIGNED MOLECULES (FR) | 1998-05-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070232622-A1 | Small molecule toll-like receptor (TLR) antagonists | TLR3, TLR8, TLR7 | CHRM2 1453/4885CHRM4 675/4885CHRM5 334/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.